Company:  AXOGEN, INC. (AXGN)
Form Type:  8-K
Filing Date:  9/11/2013 
CIK:  0000805928 
Address:  13859 PROGRESS BLVD
SUITE 100
 
City, State, Zip:  ALACHUA, Florida 32615 
Telephone:  (386) 462-6817 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.25  
Change: 
-0.10 (-1.20%)  
Trade Time: 
Dec 09  
Market Cap: 
$271.41M
Trade AXGN now with 

© 2016  
Description of Business
We are a leading medical technology company dedicated to peripheral nerve repair. We provide products and education to improve surgical treatment algorithms for peripheral nerve injuries. Our portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.
Register and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Information
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits
    SIGNATURE
    EXHIBIT INDEX
  EXHIBIT 99.1